Knoop, Christiane

Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial

Heijerman, H. G. M., McKone, E. F., Downey, D. G., Van Braeckel, E., Rowe, S. M., Tullis, E., Mall, M. A., Welter, J. J., Ramsey, B. W., McKee, C. M., et al. (2019) · The Lancet

Cystic Fibrosis Research AdvancesPharmacogenetics and Drug Metabolism

Cited by 1,414

International guidelines for the selection of lung transplant candidates: 2006 update—a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation

Orens, J. B., Estenne, M., Arcasoy, S., Conte, J. V., Corris, P., Egan, J. J., Egan, T., Keshavjee, S., Knoop, C., Kotloff, R., et al. (2006) · The Journal of Heart and Lung Transplantation

Transplantation: Methods and OutcomesOrgan Donation and Transplantation

Cited by 1,073

Fibrate‐induced increase in blood urea and creatinine: is gemfibrozil the only innocuous agent?

Broeders, N., Knoop, C., Antoine, M., Tielemans, C., & Abramowicz, D. (2000) · Nephrology Dialysis Transplantation

Acute Kidney Injury ResearchRenal Transplantation Outcomes and Treatments

Cited by 163

Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation

Treede, H., Glanville, A. R., Klepetko, W., Aboyoun, C., Vettorazzi, E., Lama, R., Bravo, C., Knoop, C., Aubert, J.-D., & Reichenspurner, H. (2012) · The Journal of Heart and Lung Transplantation

Transplantation: Methods and OutcomesRenal Transplantation Outcomes and Treatments

Cited by 130